News

Sanjiv Agarwala will serve as principal investigator at the new center, located at St Luke’s Hospital & Health Network, in Bethlehem, Pennsylvania. Over the next several months, the

Pacgen has also appointed Kevin McGarry, current director, as lead independent director of the board. These appointments follow the previously announced departure of Duffy DuFresne as president and

According to the company, the data supporting the FDA approval show that Treanda is effective, has a tolerable side effect profile in patients with indolent non-Hodgkin’s lymphoma (NHL)

Adenosine injection is indicated for supraventricular tachycardia in cardiac patients. Arthur Przybyl, Akorn’s president and CEO, said: “We are pleased to announce the abbreviated new drug application (ANDA)

New long-term histology results were presented from a cohort of 57 nucleoside-naive patients from rollover study ETV-901. ETV-901 provided long-term treatment with Baraclude 1mg for patients who have

In the six week, international, randomized, double-blind, placebo controlled study, 316 patients with an established diagnosis of schizoaffective disorder, who were experiencing acute symptoms, received either 6mg/day or

These new data show that patients who received Viread for up to 96 weeks experienced sustained suppression of hepatitis B virus (HBV) levels in the blood (91% and

ColonView testing can be used for simple and cost-effective identification of patients with fecal occult blood, which is a well-known marker for colorectal cancer and pre-cancerous large adenomas.

These studies have demonstrated that AVN-101 is safe and well tolerated, and that it has a favorable pharmacokinetic profile. Based on these and other results, the company plans